Raised serum levels of interleukins 6 and 8 and antiphospholipid antibodies in an adult patient with Henoch-Schönlein purpura

Clinical and Experimental Dermatology

Volumn 38, Issue 7, 2013, Pages 730-736

  Kimura, S ^a   Takeuchi, S ^a   Soma, Y ^a   Kawakami, T ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIPHOSPHATIDYLSERINE PROTHROMBIN COMPLEX ANTIBODY; ANTISTREPTOLYSIN; C REACTIVE PROTEIN; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 6; INTERLEUKIN 8; PHOSPHOLIPID ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ANAPHYLACTOID PURPURA; ANTIBODY BLOOD LEVEL; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHRITIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTIPHOSPHOLIPID; ANTISTREPTOLYSIN; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HUMANS; IMMUNOGLOBULIN A; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PURPURA, SCHOENLEIN-HENOCH; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84884857920     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12089     Document Type: Article

References (24)

1. Kawakami T, Watabe H, Mizoguchi M, Soma Y,. Elevated serum IgA anticardiolipin antibody levels in adult Henoch-Schönlein purpura. Br J Dermatol 2006; 155: 983-7.
2. Kawakami T, Yamazaki M, Mizoguchi M, Soma Y,. High titer of serum antiphospholipid antibody levels in adult Henoch-Schönlein purpura and cutaneous leukocytoclastic angiitis. Arthritis Rheum 2008; 59: 561-7.
3. Kharbanda RK, Walton B, Allen M, et al,. Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin. Circulation 2002; 105: 2600-4.
4. Castell JV, Gomez-Lechon MJ, David M, et al,. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS 1988; 232: 347-50.
5. Veldhuis J, Willemse PHB, Sleijfer DT, et al,. Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer. J Clin Oncol 1995; 13: 2585-93.
6. Nakahara H, Song J, Sugimoto M, et al,. Anti-interleukin-6 receptor antibody therapy reduces vascular endothelial growth factor production in rheumatoid arthritis. Arthritis Rheum 2003; 48: 1521-9.
7. Bosch I, Xhaja K, Estevez L, et al,. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J Virol 2002; 76: 5588-97.
8. Hirani N, Antonicelli F, Strieter RM, et al,. The regulation of interleukin-8 by hypoxia in human macrophages-a potential role in the pathogenesis of the acute respiratory distress syndrome (ARDS). Mol Med 2001; 7: 685-97.
9. Cheon H, Yu SJ, Yoo DH, et al,. Increased expression of pro-inflammatory cytokines and metalloproteinase-1 by TGF-β1 in synovial fibroblasts from rheumatoid arthritis and normal individuals. Clin Exp Immunol 2002; 127: 547-52.
10. Niemir ZI, Stein H, Ciechanowicz A, et al,. The in situ expression of interleukin-8 in the normal human kidney and in different morphological forms of glomerulonephritis. Am J Kidney Dis 2004; 43: 983-98.
11. Mills JA, Michel BA, Bloch DA, et al,. The American College of Rheumatology 1990 criteria for the classification of Henoch-Schönlein purpura. Arthritis Rheum 1990; 33: 1114-21.
12. Kawakami T,. New algorithm (KAWAKAMI algorithm) to diagnose primary cutaneous vasculitis. J Dermatol 2010; 37: 113-24.
13. Miyakis S, Lockshin MD, Atsumi T, et al,. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
14. Nishizono I, Iida S, Suzuki N, et al,. Rapid and sensitive chemiluminescent enzyme immunoassay for measuring tumor markers. Clin Chem 1991; 37: 1639-44.
15. Kawakami T, Ooka S, Mizoguchi M, et al,. Remission of hepatitis B virus-related cryoglobulinemic vasculitis with entecavir. Ann Intern Med 2008; 149: 911-12.
16. Kawakami T, Yamazaki M, Mizoguchi M, Soma Y,. High titer of anti-phosphatidylserine-prothrombin complex antibodies in patients with cutaneous polyarteritis nodosa. Arthritis Rheum 2007; 57: 1507-13.
17. Cronstein BN,. Interleukin-6-a key mediator of systemic and local symptoms in rheumatoid arthritis. Bull NYU Hosp Jt Dis 2007; 65 (Suppl. 1): S11-5.
18. Yang YH, Lai HJ, Huang CM, et al,. Sera from children with active Henoch-Schönlein purpura can enhance the production of interleukin 8 by human umbilical venous endothelial cells. Ann Rheum Dis 2004; 63: 1511-3.
19. Yang YH, Huang YH, Lin YL, et al,. Circulating IgA from acute stage of childhood Henoch-Schönlein purpura can enhance endothelial interleukin (IL)-8 production through MEK/ERK signalling pathway. Clin Exp Immunol 2006; 144: 247-53.
20. Vega-Ostertag M, Casper K, Swerlick R, et al,. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum 2005; 52: 1545-54.
21. Chartapisak W, Opastiraku S, Willis NS, et al,. Prevention and treatment of renal disease in Henoch-Schönlein purpura: a systematic review. Arch Dis Child 2009; 94: 132-7.
22. Sutherland F, Cunningham H, Pontikes L, et al,. Elevated serum interleukin 6 levels in patients with acute intestinal ischemia. Hepatogastroenterology 2003; 50: 419-21.
23. Fonseca JE, Santos MJ, Canhão H, Choy E,. Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmun Rev 2009; 8: 538-42.
24. al-Sheyyab M,., el-Shanti H, Ajlouni S, et al,. Henoch-Schönlein purpura: clinical experience and contemplations on a streptococcal association. J Trop Pediatr 1996; 42: 200-3.